BRCA1 and neoplasm: This study aimed to compare long-term outcomes of young, node-negative, (neo)adjuvant chemotherapy-naïve TNBC patients according to gBRCA1m, sBRCA1m, or tumor BRCA1-PM, or according to BRCA1-like status, taking into account TILs and other established clinicopathological characteristics.